Cannabinoid Receptor Localization in Brain: Relationship to Motor and Reward Systems

Annals of the New York Academy of Sciences

Volumn 654, Issue 1, 1992, Pages 19-32

  HERKENHAM, MILES ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDROXYDOPA; BRAIN RECEPTOR; CANNABINOID; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DRUG RECEPTOR; IBOTENIC ACID;

ANIMAL TISSUE; BASAL GANGLION; CONFERENCE PAPER; DOG; DRUG RECEPTOR BINDING; GRANULE CELL; GUINEA PIG; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LIMBIC SYSTEM; MALE; MOTOR SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT; REWARD; RHESUS MONKEY; SUBSTANTIA NIGRA;

ANIMAL; AUTORADIOGRAPHY; BRAIN; CANNABINOIDS; CORPUS STRIATUM; CYCLOHEXANOLS; DOPAMINE; GUINEA PIGS; HUMAN; MACACA MULATTA; MALE; MOTOR ACTIVITY; RATS; RATS, INBRED STRAINS; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DRUG; REWARD; TRITIUM;

EID: 0026699103     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1992.tb25953.x     Document Type: Article

References (59)

1. Cannabis. Its chemistry, pharmacology, and toxicology
2. The pharmacohistory of Cannabis sativa
3. Isolation, structure, and partial synthesis of an active constituent of hashish.
4. Chemical basis of hashish activity.
5. Cannabinoid chemistry
6. Cannabinoid pharmacology.
7. Health aspects of cannabis.
8. Cellular effects of cannabinoids.
9. Epidemiology of drug abuse: An overview.
10. Position statement on psychoactive substance use and dependence: Update on marijuana and cocaine.
11. Newborn outcomes with maternal marihuana use in Jamaican women.
12. Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs.
13. Determination and characterization of a cannabinoid receptor in rat brain.
14. Characterization and localization of cannabinoid receptors in brain: An in vitro technique using slide‐mounted tissue sections.
15. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study.
16. Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: Fluorescent studies
17. The central neuropharmacology of psychotropic cannabinoids.
18. 9‐Tetrahydrocannabinol increases arachadonic acid levels in guinea pig cerebral cortex slices
19. The cannabinoid receptor: Biochemical, anatomical and behavioral characterization
20. Behavioral comparisons of the stereoisomers of tetrahydrocannabinols
21. Human pharmacology of 1S and 1R enantiomers of delta‐3‐tetrahydrocannabinol
22. Analgesic properties of the tetrahydrocannabinols, their metabolites, and analogs
23. 9‐Nor‐9‐hydroxyhexahydrocannabinols. Synthesis, some behavioral and analgesic properties, and comparison with the tetrahydrocannabinols
24. Some 9‐hydroxycannabinoid‐like compounds. Synthesis and evaluation of analgesic and behavioral properties.
25. The discovery of nonclassical cannabinoid analgetics
26. Nonclassical cannabinoid analgesics inhibit adenylate cyclase: Development of a cannabinoid receptor model.
27. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.
28. Cannabinoid receptor localization in brain.
29. 2 dopamine receptor autoradiography: High percentage of high‐affinity agonist sites and increased nucleotide sensitivity in tissue sections.
30. Comparative distribution of dopamine D‐1 and D‐2 receptors in the basal ganglia of turtle, pigeon, rat, cat, and monkey
31. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
32. Quantitative autoradiography of the dopamine uptake complex in the central nervous system.
33. 3H]GBR 12935: Binding characteristics.
34. Benzodiazepine receptor sites in the human brain: Autoradiographic mapping.
35. 2 subtypes of dopamine receptors in rat brain.
36. 3H]glutamate binding sites in rat central nervous system.
37. Comparison of ibotenate and kainate neurotoxicity in rat brain: A histological study.
38. 1 receptor containing striatal neurons.
39. Structure of a cannabinoid receptor: Functional expression of the cloned cDNA
40. 9‐tetrahydrocannabinol on potassium‐evoked release of dopamine in the rat caudate nucleus: An in vivo electrochemical and in vivo microdialysis study.
41. 9‐Tetrahydrocannabinol produces naloxone‐blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely‐moving rats as measured by intracerebral microdialysis
42. Brain‐stimulation reward: A model for the neuronal bases for drug‐induced euphoria
43. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.
44. 9‐tetrahydrocannabinol in rhesus monkeys.
45. Failure to obtain “cannabis‐directed behavior” and abstinence syndrome in rats chronically treated with cannabis sativa extracts
46. 9‐tetrahydrocannabinol.
47. 9‐tetrahydrocannabinol in laboratory rats is mirrored by strain‐specific facilitation of presynaptic dopamine efflux in nucleus accumbens.
48. Marijuana: Acute effects on human memory
49. The hippocampus and behavior.
50. Representation in the hippocampus: What do hippocampal neurons encode
51. Increased susceptibility to memory intrusions and the Stroop interference effect during acute marijuana intoxication
52. Acute effects of Δ‐9‐tetranydrocannabinol in rhesus monkeys as measured by performance in a battery of complex operant tests.
53. 9‐tetrahydrocannabinol on sensory‐evoked discharges of granule cells in the dentate gyrus of behaving rats.
54. Treatment of torsion dystonia
55. Treatment of human spasticity with delta‐9‐tetrahydrocannabinol
56. Tetrahydrocannabinol for tremor in multiple sclerosis.
57. Effect of cannabinoids on spasticity and ataxia in multiple sclerosis.